Role of TGF-β1 in vascular smooth muscle cell apoptosis induced by Angiotensin II

European Journal of Pharmacology

Volumn 556, Issue 1-3, 2007, Pages 36-44

  Redondo, Santiago ^a   Ruiz, Emilio ^a   Padilla, Eugenia ^a   Gordillo Moscoso, Antonio ^a   Tejerina, Teresa ^a  

^a SCHOOL OF MEDICINE   (Spain)

Author keywords

Angiotensin; Apoptosis; Transforming growth factor beta; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN II; BROXURIDINE; CYTOKINE; DNA FRAGMENT; IRBESARTAN; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; 1,3 DIOXOLANE DERIVATIVE; 4 (5 BENZO(1,3)DIOXOL 5 YL 4 PYRIDIN 2 YL 1H IMIDAZOL 2 YL)BENZAMIDE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; ACTIVIN RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZAMIDE DERIVATIVE; BIPHENYL DERIVATIVE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL FUNCTION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL CALF SERUM; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE; ANIMAL; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; PHYSIOLOGY; SMOOTH MUSCLE FIBER; WISTAR KYOTO RAT;

ACTIVIN RECEPTORS; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; BENZAMIDES; BIPHENYL COMPOUNDS; CELL PROLIFERATION; CELLS, CULTURED; DIOXOLES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED WKY; TETRAZOLES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33846037284     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.10.060     Document Type: Article

References (40)

1. Bascands J.L., Girolami J.P., Troly M., Escargueil-Blanc I., Nazzal D., Salvayre R., and Blaes N. Angiotensin II induces phenotype-dependent apoptosis in vascular smooth muscle cells. Hypertension 38 (2001) 1294-1299
2. Bhaskaran M., Reddy K., Radhakrishanan N., Franki N., Ding G., and Singhal P.C. Angiotensin II induces apoptosis in renal proximal tubular cells. Am. J. Physiol. Renal Physiol. 284 (2003) F955-F965
3. Boffa J.J., Lu Y., Placier S., Stefanski A., Dussaule J.C., and Chatziantoniou C. Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases. J. Am. Soc. Nephrol. 14 (2003) 1132-1144
4. Border W.A., and Noble N. Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension 31 (1998) 181-188
5. Cambien F., Ricard S., Troesch A., Mallet C., Generenaz L., Evans A., Arvelier D., Luc G., Ruidavets J.B., and Poirier O. Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28 (1996) 881-887
6. Chung I.M., Gold H.K., Schwartz S.M., Ikari Y., Reidy M.A., and Wight T.N. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J. Am. Coll. Cardiol. 40 (2002) 2072-2081
7. Dahlfors G., Chen Y., Wasteson M., and Arnqvist H.J. PDGF-BB-induced DNA synthesis is delayed by angiotensin II in vascular smooth muscle cells. Am. J. Physiol. 274 (1998) 1742-1748
8. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J. Clin. Invest. 105 (2000) 1605-1612
9. Daugherty A., Manning M.W., and Cassis L.A. Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br. J. Pharmacol. 134 (2001) 865-870
10. De Gasparo M., Catt K.J., Inagami T., Wright J.W., and Unger T. International Union of Pharmacology XXIII. The angiotensin II receptors. Pharmacol. Rev. 52 (2000) 415-472
11. Ford C.M., Li S., and Pickering J.G. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT1 receptor, transforming growth factor-beta, and tyrosine phosphorylation. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1843-1851
12. Grainger D.J. Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 399-404
13. Inman G.J., Nicolas F.J., Callahan J.F., Harling J.D., Gaster L.M., Reith A.D., Laping N.J., and Hill C.S. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol. Pharmacol. 62 (2002) 65-74
14. Ivanov V.O., Rabovsky A.B., Ivanova S.V., and Niedzwiecki A. Transforming growth factor beta 1 and ascorbate regulate proliferation of cultured smooth muscle cells by independent mechanisms. Atherosclerosis 140 (1998) 25-34
15. Jinin M., Ihn H., and Tamaki K. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol. Pharmacol. 69 (2006) 597-607
16. Kalinina N., Agrotis A., Antropova Y., Ilyinskaya O., Smirnov V., Taratak E., and Bobik A. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 1391-1396
17. Kamada Y., Tamura S., Kiso S., Fukui K., Doi Y., Ito N., Terui Y., Saito T., Watanabe H., Togashi H., Kawata S., and Matsuzawa Y. Angiotensin II stimulates the nuclear translocation of Smad2 and induces PAI-1 mRNA in rat hepatic stellate cells. Hepatol. Res. 25 (2003) 296-305
18. Kropf J., Schurek J.O., Wollner A., and Gressner A.M. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin. Chem. 43 (1997) 1965-1974
19. Landmesser U., Cai H., Dikalov S., McCann L., Hwang J., Jo H., Holland S.M., and Harrison D.G. Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40 (2002) 511-515
20. Laviades C., Varo N., and Diez J. Transforming growth factor beta in hypertensives with cardio renal damage. Hypertension 36 (2000) 517-522
21. Lavoie P., Robitaille G., Agharazii M., Ledbetter S., Lebe I.M., and Lariviere R. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats. J. Hypertens. 23 (2005) 1895-1903
22. Lijnen P.J., Petrov V.V., and Fagard R.H. Association between transforming growth factor-beta and hypertension. Am. J. Hypertens. 16 (2003) 604-611
23. Limone P., Berardi C., Pomero F., Del Rizzo P., Allione A., Beltramo E., D'alu F., Ponte E., Pellissetto C., Lacaria A., Barberis A.M., and Porta M. q Failure of angiotensin II and insulin to stimulate transforming growth factor-beta1 release from cultured bovine retinal pericytes. Diabetes Metab. 8 (2002) 499-503
24. Lindschau C., Quass P., Menne J., Guler F., Fiebeler A., Leitges M., Luft F.C., and Haller H. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha. Hypertension 42 (2003) 335-341
25. Liu X., Nagarajan R.P., Vale W., and Chen Y. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor. FEBS Lett. 519 (2002) 93-98
26. Lutgens E., Gijbels M., Smook M., Heeringa P., Gotwals P., Koteliansky V.E., and Daemen M.J. Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 975-982
27. Mayr M., Hu Y., Hainaut H., and Xu Q. Mechanical stress-induced DNA damage and rac-p38MAPK signal pathways mediate p53-dependent apoptosis in vascular smooth muscle cells. FASEB J. 16 (2002) 1423-1425
28. MAPK and JNK: a mechanism for activation of latent TGF-beta1. Am. J. Physiol. Renal Physiol. 286 (2004) 278-287
29. Qin X.P., Ye F., Hu C.P., Liao D.F., Deng H.W., and Li Y.J. Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells. Eur. J. Pharmacol. 488 (2004) 45-49
30. Redondo S., Santos-Gallego C.G., Ganado P., Garcia M., Rico L., Del Rio M., and Tejerina T. Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-beta. Circulation 107 (2003) 626-629
31. Rodriguez-Vita J., Sanchez-Lopez E., Esteban V., Ruperez M., Egido J., and Ruiz-Ortega M. Angiotensin II activates the Smad pathway in vascular smooth muscle cells by a transforming growth factor-beta-independent mechanism. Circulation 111 (2005) 2509-2517
32. Rosenkranz S. TGF-beta1 and angiotensin networking in cardiac remodelling. Cardiovasc. Res. 63 (2004) 423-432
33. Sasso F.C., Carbonara O., Persico E., D'Ambrosio R., Coppola L., Nasti R., Campana B., Moschella S., Torella R., and Cozzolino D. Increased vascular endothelial growth factor mRNA expression in the heart of streptozotocin-induced diabetic rats. Metabolism 52 (2003) 675-678
34. Siegert A., Ritz E., Orth E., and Wagner J. Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle. J. Mol. Med. 77 (1997) 437-445
35. Suzuki J., Iwai M., Nakagami H., Wu L., Chen R., Sugaya T., Hamada M., Hiwada K., and Horiuchi M. Role of angiotensin II-regulated apoptosis through distinct AT1 and AT2 receptors in neointimal formation. Circulation 106 (2002) 847-853
36. Ten Dijke P., and Hill C. New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29 (2004) 265-273
37. Touyz R.M. Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Braz. J. Med. Biol. Res. 37 (2004) 1263-1273
38. Wenzel S., Taimor G., Piper H.M., and Schluter K.D. Redox-sensitive intermediates mediate angiotensin II-induced p38 MAP kinase activation, AP-1 binding activity, and TGF-beta expression in adult ventricular cardiomyocytes. FASEB J. 15 (2001) 2291-2293
39. Xiao F., Puddefoot J.R., Barker S., and Vinson G.P. Mechanism for aldosterone potentiation of angiotensin II-stimulated rat arterial smooth muscle cell proliferation. Hypertension 44 (2004) 340-345
40. Yokota M., Ichihara S., Lin T.L., Nakashima N., and Yamada Y. Association of a T29- ->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101 (2000) 2783-2787